Drug Class
HMG-CoA reductase inhibitor
Type
brand
Active Ingredient
toripalimab
📋Overview
Loqtorzi is a medication that belongs to the class of immune checkpoint inhibitors, specifically targeting the PD-1 pathway. It is used in the management of certain types of cancers, such as head and neck squamous cell carcinoma. By modulating the immune system, it helps the body recognize and attack cancer cells. Loqtorzi is part of a broader group of therapies designed to enhance the immune response against tumors.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Loqtorzi
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.